单孔与多孔机器人辅助前列腺及肾脏手术的系统综述与荟萃分析比较
该系统综述与荟萃分析比较单孔与多孔机器人辅助前列腺及肾脏手术的围手术期、功能与肿瘤学结局。单孔在前列腺癌根治术和肾部分切除术中降低术后疼痛和住院时间,但肾部分切除术中热缺血时间较长,功能与肿瘤学结局在根治性前列腺切除术中相当。
要点
- 单孔机器人前列腺癌根治术可减少出血、缩短住院并减轻术后疼痛。
- 单孔与多孔机器人肾部分切除术相比热缺血时间较长,但住院时间和术后第1天疼痛评分更优。
- 根治性前列腺切除术中单孔与多孔的功能和肿瘤学结局相当。
核心结论
- 与多孔机器人手术相比,单孔机器人手术在减少术后疼痛和住院时间方面具有优势。
- 根治性前列腺切除术中两种入路的功能与肿瘤学结局相当;肾部分切除术中单孔热缺血时间较长。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE和Scopus数据库截至2024年12月发表的文献。
- 纳入比较单孔与多孔机器人辅助手术的研究,涵盖根治性前列腺切除术26项、简单前列腺切除术3项、肾部分切除术9项、根治性肾切除术1项和肾盂成形术2项。
主要发现
- 与多孔机器人根治性前列腺切除术相比,单孔与较低的估计失血量(SMD=0.51;95%CI:0.16-0.87)、较短的住院时间(SMD=1.12;95%CI:0.63-1.62)和减轻的术后疼痛(SMD=0.12;95%CI:0.04-0.35)相关。
- 单孔与多孔机器人简单前列腺切除术的唯一差异是多孔组使用更高的吗啡毫克当量(SMD=0.59;95%CI:0.01-1.16)。
- 肾部分切除术中单孔与显著更高的热缺血时间相关(SMD=-0.32;95%CI:-0.58至-0.06),但住院时间(SMD=0.31;95%CI:0.03-0.59)和术后第1天疼痛评分(SMD=0.22;95%CI:0.01-0.43)显著有利于单孔。
临床怎么用
- 在前列腺癌根治术和肾部分切除术中,单孔机器人手术可考虑用于减少术后疼痛和缩短住院时间。
- 肾部分切除术中采用单孔入路需注意热缺血时间可能延长。
局限性
- 缺乏随机对照试验。
- 手术技术和结局定义存在跨研究异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The aim of this systematic review with meta-analysis was to assess the perioperative, functional, and oncological outcomes of single-port (SP) robotic procedures in the surgical management of prostate and renal diseases. METHODS: A systematic review was conducted using the MEDLINE and Scopus databases, covering literature published up to December 2024. Studies were included if these compared SP versus multiport (MP) approaches in robot-assisted procedures, specifically radical prostatectomy (RARP), simple prostatectomy (RASP), partial nephrectomy (RAPN), radical nephrectomy (RARN), and pyeloplasty (RAP; PROSPERO registration number: CRD42025616519). Perioperative outcomes were assessed across all procedures. Functional and oncological outcomes were analysed specifically in patients undergoing RARP, while warm ischaemia time (WIT), off-clamp rates, and positive surgical margin rates were evaluated in those undergoing RAPN. KEY FINDINGS AND LIMITATIONS: A total of 26, three, nine, one, and two studies evaluated RARP, RASP, RAPN, RARN, and RAP, respectively. Compared with MP-RARP, SP-RARP was associated with lower estimated blood loss (standardised mean difference [SMD] = 0.51; 95% confidence interval [CI]: 0.16-0.87), shorter length of stay (SMD = 1.12; 95% CI: 0.63-1.62), and reduced postoperative pain (SMD = 0.12; 95% CI: 0.04-0.35). The only difference between SP- and MP-RASP was represented by the use of a higher morphine milligram equivalent in the MP group (SMD = 0.59; 95% CI: 0.01-1.16). In patients undergoing RAPN, SP was associated with a significantly higher WIT than MP (SMD = -0.32; 95% CI: -0.58 to -0.06). However, the length of hospital stay (SMD = 0.31; 95% CI: 0.03-0.59) and pain score on postoperative day 1 (SMD = 0.22; 95% CI: 0.01-0.43) were significantly in favour of SP-RAPN. Limitations were the lack of randomised trials, and the across-study heterogeneity in surgical techniques and outcome definitions. CONCLUSIONS AND CLINICAL IMPLICATIONS: Compared with the MP approach, SP robotic surgery offers advantages in terms of reduced postoperative pain and hospital stay. In patients undergoing RARP, functional and oncological outcomes were comparable between the two approaches. In patients undergoing RAPN, the SP approach was associated with a longer WIT.
引用
- Ficarra V, Romito I, Sorce G, et al. Comparison of Single- and Multiport Robot-assisted Approaches in Prostate and Renal Surgery: A Systematic Review and Meta-analysis. Eur Urol. 2025. PMID: 41016915. doi:10.1016/j.eururo.2025.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。